These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33619277)

  • 1. Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus.
    Bullard BL; Corder BN; DeBeauchamp J; Rubrum A; Korber B; Webby RJ; Weaver EA
    Nat Commun; 2021 Feb; 12(1):1203. PubMed ID: 33619277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study.
    Henry C; Palm AE; Utset HA; Huang M; Ho IY; Zheng NY; Fitzgerald T; Neu KE; Chen YQ; Krammer F; Treanor JJ; Sant AJ; Topham DJ; Wilson PC
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31434733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.
    Weldon WC; Martin MP; Zarnitsyn V; Wang B; Koutsonanos D; Skountzou I; Prausnitz MR; Compans RW
    Clin Vaccine Immunol; 2011 Apr; 18(4):647-54. PubMed ID: 21288996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant protein containing influenza viral conserved epitopes and superantigen induces broad-spectrum protection.
    Li Y; Xu M; Li Y; Gu W; Halimu G; Li Y; Zhang Z; Zhou L; Liao H; Yao S; Zhang H; Zhang C
    Elife; 2021 Nov; 10():. PubMed ID: 34783655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses.
    Reneer ZB; Skarlupka AL; Jamieson PJ; Ross TM
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33692193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.
    Wang B; Yu H; Yang FR; Huang M; Ma JH; Tong GZ
    Virol J; 2012 Jun; 9():127. PubMed ID: 22738661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans.
    Nachbagauer R; Wohlbold TJ; Hirsh A; Hai R; Sjursen H; Palese P; Cox RJ; Krammer F
    J Virol; 2014 Nov; 88(22):13260-8. PubMed ID: 25210189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice.
    Muramatsu M; Yoshida R; Miyamoto H; Tomabechi D; Kajihara M; Maruyama J; Kimura T; Manzoor R; Ito K; Takada A
    PLoS One; 2013; 8(8):e71534. PubMed ID: 23977065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin.
    Weaver EA; Rubrum AM; Webby RJ; Barry MA
    PLoS One; 2011 Mar; 6(3):e18314. PubMed ID: 21464940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chimeric influenza hemagglutinin delivered by parainfluenza virus 5 vector induces broadly protective immunity against genetically divergent influenza a H1 viruses in swine.
    Li Z; Zaiser SA; Shang P; Heiden DL; Hajovsky H; Katwal P; DeVries B; Baker J; Richt JA; Li Y; He B; Fang Y; Huber VC
    Vet Microbiol; 2020 Nov; 250():108859. PubMed ID: 33039727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice.
    Choi A; Bouzya B; Cortés Franco KD; Stadlbauer D; Rajabhathor A; Rouxel RN; Mainil R; Van der Wielen M; Palese P; García-Sastre A; Innis BL; Krammer F; Schotsaert M; Mallett CP; Nachbagauer R
    Immunohorizons; 2019 Apr; 3(4):133-148. PubMed ID: 31032479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Heterologous Prime-Boost Vaccination with H3N2 Influenza Viruses in Pre-Immune Individuals: Studies in the Pig Model.
    Chepkwony S; Parys A; Vandoorn E; Chiers K; Van Reeth K
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32882956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
    Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
    Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying Unique Molecular Identifiers in Next Generation Sequencing Reveals a Constrained Viral Quasispecies Evolution under Cross-Reactive Antibody Pressure Targeting Long Alpha Helix of Hemagglutinin.
    Hauck NC; Kirpach J; Kiefer C; Farinelle S; Maucourant S; Morris SA; Rosenberg W; He FQ; Muller CP; Lu IN
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29587397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.